Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000192

Chairperson & CEO sold 5,410 shares at an average $578.83 ($3,131,476)

  • Chairperson & CEO acquired 5,410 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

16 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-18 Exercise or conversion : show line 1 in the form 10b5-1 +5,410 $117.76 $637,082 329,853 I
2026-11-18 Sale : show line 2 in the form 10b5-1 −120 $570.82 $68,498 329,733 I
2026-11-18 Sale : show line 3 in the form 10b5-1 −80 $571.63 $45,731 329,653 I
2026-11-18 Sale : show line 4 in the form 10b5-1 −140 $573.40 $80,276 329,513 I
2026-11-18 Sale : show line 5 in the form 10b5-1 −259 $574.36 $148,758 329,254 I
2026-11-18 Sale : show line 6 in the form 10b5-1 −201 $575.26 $115,628 329,053 I
2026-11-18 Sale : show line 7 in the form 10b5-1 −440 $576.65 $253,727 328,613 I
2026-11-18 Sale : show line 8 in the form 10b5-1 −909 $577.59 $525,033 327,704 I
Open-market sales · 5,410 sh · avg $578.83 · $3,131,476

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2026-11-18 Exercise or conversion : show line 17 in the form 10b5-1 Stock Option −5,410 $117.76 2027-03-15 5,410 0 I
Loading xslF345X06/primarydocument.xml…